TY  - JOUR

T1  - Estimating lifetime benefits associated with immuno-oncology therapies : challenges and approaches for overall survival extrapolations

JO  - PharmacoEconomics

PY  - 2019/09/01

AU  - Ouwens MJNM

AU  - Mukhopadhyay P

AU  - Zhang Y

AU  - Huang M

AU  - Latimer N

AU  - Briggs A

ED  - 

DO  - DOI: 10.1007/s40273-019-00806-4

PB  - Springer Nature

VL  - 37

IS  - 9

SP  - 1129

EP  - 1138

Y2  - 2025/10/31

ER  -